威高血净：11月20日召开董事会会议

Group 1 - The core point of the article is that Weigao Blood Products (SH 603014) held its 18th meeting of the second board of directors on November 20, 2025, to review proposals including capital increase in joint ventures and related transactions [1] - For the first half of 2025, Weigao Blood Products reported that its revenue composition was as follows: consumables accounted for 77.55%, equipment accounted for 18.25%, other businesses accounted for 2.35%, and other categories accounted for 1.85% [1] - As of the time of reporting, Weigao Blood Products had a market capitalization of 16.8 billion yuan [1]